Drug Type Small molecule drug |
Synonyms acrivastina, BW-825C, Benadryl Allergy Relief |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United Kingdom (17 Sep 1997), |
Regulation- |
Molecular FormulaC22H24N2O2 |
InChIKeyPWACSDKDOHSSQD-IUTFFREVSA-N |
CAS Registry87848-99-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02760 | Acrivastine |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Allergic skin reaction | China | 27 May 2000 | |
| Dermatographic urticaria | China | 27 May 2000 | |
| Eczema | China | 27 May 2000 | |
| Rhinitis, Allergic, Seasonal | China | 27 May 2000 | |
| Urticaria | China | 27 May 2000 | |
| Chronic Urticaria | United Kingdom | 17 Sep 1997 | |
| Rhinitis, Allergic | United Kingdom | 17 Sep 1997 |





